Page last updated: 2024-08-23

etoposide and gsk2830371

etoposide has been researched along with gsk2830371 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, WM; Chen, Z; Dou, J; Guan, S; Liu, S; Nuchtern, JG; Pang, JC; Patel, R; Shi, Y; Vasudevan, SA; Wang, L; Wang, Y; Xu, X; Yang, J; Yang, T; Yao, D; Yu, Y; Zhang, H; Zhao, Y	1

Other Studies

1 other study(ies) available for etoposide and gsk2830371

Article	Year
Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis. Scientific reports, 2016, 12-19, Volume: 6 Topics: Aminopyridines; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Checkpoint Kinase 2; Dipeptides; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Mice; Neuroblastoma; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2016

Article

Year

Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis.

Scientific reports, 2016, 12-19, Volume: 6

Topics: Aminopyridines; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Checkpoint Kinase 2; Dipeptides; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Mice; Neuroblastoma; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2016